Phreesia Inc (PHR)
Phreesia Investor Relations - Phreesia Sets Release Date for Fiscal Second Quarter 2026 Results
Lifecore Biomedical (LFCR)
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
Biodesix Inc (BDSX)
Biodesix Announces Second Quarter 2025 Results and Highlights
Relay Therapeutics (RLAY)
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
NextCure Inc (NXTC)
NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results
Alector Inc (ALEC)
Alector Reports Second Quarter 2025 FinancialResults and Provides Business Update
Regeneron Pharmaceuticals Inc (REGN)
Regeneron Announces Investor Conference Presentations
Pacific Biosciences of California Inc (PACB)
PacBio Announces Second Quarter 2025 Financial Results
Zymeworks Inc (ZYME)
Zymeworks Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Eton Pharmaceuticals Inc. (ETON)
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results
ICU Medical Inc (ICUI)
ICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance
SenesTech Inc (SNES)
SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins
Pliant Therapeutics Inc (PLRX)
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Atea Pharmaceuticals Inc (AVIR)
Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update